Increased buprenorphine prescribing following implementation of a low-barrier virtual prescriber network.

Zoe Lindenfeld¹, Michael L Barnett², Jialiang Hua³, Stephen Crystal⁴

¹Edward J. Bloustein School of Planning and Public Policy, Rutgers University, New Brunswick, NJ, 08901, USA. Electronic address: Zoe.Lindenfeld@Rutgers.edu.

²Department of Health Services, Policy, and Practice, Brown School of Public Health, Providence, RI, USA.

³Center for Health Services Research, Rutgers Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ, USA.

⁴Center for Health Services Research, Rutgers Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ, USA; Rutgers School of Social Work, New Brunswick, NJ, USA.

PubMed DOI

Abstract

INTRODUCTION: Rates of buprenorphine receipt have stagnated across the United States despite high overdose mortality and federal policy changes designed to increase prescribing. In March 2023, the city of Paterson, New Jersey (NJ) implemented RealFix, a municipal initiative focused on rapid induction and delivery of buprenorphine. RealFix uses a walk-in model and a virtual provider-hub service to…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.